Pseudohypoparathyroidism is a complex disorder of renal resistance to parathyroid hormone the mechanism of which is unclear. It is often associated with skeletal abnormalities and there may also be other hormonal defects. This is an extensive endocrinological investigation of five of six affected members in two generations of one family. The phenotypic variability of the syndrome is explored: four members had hypothyroidism; two had abnormal gonadal function; all five had abnormal prolactin response to TRH; one had abnormal hepatic response to glucagon infusion. All had normal hypothalamic-pituitary-adrenal axes, renal responsiveness to vasopressin and growth hormone responses to a variety of stimuli. Special note is made of oral pathology, and evidence of platelet aggregation abnormalities is presented which has not previously been described in the syndrome.
INTRODUCTION
Pseudohypoparathyroidism is a rare familial disease with a variable pattern of inheritance [1] [2] [3] , first described by Albright and colleagues in 1942 [4] , It is characterized by specific somatic features (later termed Albright's hereditary osteodystrophy) and the symptoms and signs of hypoparathyroidism with biochemical evidence of hypocalcaemia and hyperphosphataemia, but normal or raised levels of parathyroid hormone [PTH] [5] [6] [7] [8] . The somatic and biochemical features may occur independently [9, 10] . Other endocrine abnormalities often coexist [11] [12] [13] [14] and this has led to some debate as to the pathophysiology of the disorder.
The following report concerns the occurrence of pseudohypoparathyroidism in one large affected family, five members of which underwent extensive biochemical and endocrinological investigation. The aim was to see the profile of abnormality within a genetically related group and in particular to see whether abnormalities occurred in other hormonal axes which involve stimulation of adenylate cyclase.
METHODS

Patients
Sibling II] was referred for investigation of oligomenorrhoea. The diagnosis of pseudohypoparathyroidism was suggested by clinical features. She and four of her siblings and her mother agreed to undergo detailed investigation. The remaining living sibling was examined by one of us (PKT): no evidence of pseudohypoparathyroidism was found and biochemistry where available is presented with the data for the rest of the family.
Investigation of Parathyroid Function
Fasting blood samples were taken for basal ionized calcium (Ca 2+ ), phosphate (PO 4 ) and PTH. Each subject then underwent a modified Elseworth Howard test [15] according to Chase et al. [16] . Each received 200 units bovine PTH i.v. (courtesy NIBSC) over 30 minutes. Urine samples were collected at times -80, 0, +30, +60, +120, +180 mins and blood samples at times + 15, +45, +90, + 150 mins. Both were assayed for creatinine, Ca (total) and PO 4 .
Dynamic Endocrine Tests
Each subject underwent the following investigations on separate occasions:
Thyrotrophin releasing hormone test. 200 //g of thyrotrophin was administered i.v. Blood was taken at 0, 20, 60 minutes for assay of T 3 TSH, prolactin and growth hormone. T 3 was also measured at 4 hours post-TRH. Insulin stress test. 0.1 unit/kg human actrapid was administered i.v. Blood was taken at 30 minute intervals for assay of glucose, cortisol, and growth hormone.
Growth hormone releasing hormone test. 1 /xg/kg of growth hormone releasing hormone was administered i.v. over one minute. Blood was taken at 30 minute intervals for 2 hours for assay of growth hormone.
Glucagon infusion. After overnight fast 500 /zg glucagon was administered intravenously over one minute. Blood was taken at -15,0, + 5, +10, +15, +30, + 60 mins for glucose, growth hormone and cyclic AMP assays.
Water deprivation test. Each subject underwent an 8-hour fluid abstinence with estimation of weight, urine volume and osmolality, plasma osmolality and vasopressin at two hourly intervals.
Assessment of gonadal function. Sibling IIi had depot injections of five ampoules and three ampoules, respectively, of human menopausal gonadotrophin on days 0 and 3 with measurement of plasma oestradiol and progesterone at daily intervals for 4 days. Male siblings received depot injections of human chorionic gonadotrophin 2000 iu on days 0 and 3 with blood taken for testosterone measurement at daily intervals for 4 days.
Assay Methods
TSH, prolactin, growth hormone, luteinizing hormone, follicle stimulating hormone, T 3 and vasopressin were measured by in house radioimmunoassay. PTH was measured by in house radioimmunoassay with antibody to the N-terminus and cyclic AMP was assayed in blood and urine using the Immunonuclear kit. Normal basal ranges and response to stimuli are given with the results of this study.
Oral Examination
Oral hygiene, periodontal status and caries experience, together with the colour and morphology of the teeth, including the presence of enamel hypoplasia, was recorded in all five subjects. Panoramic radiographs of teeth and jaws were followed by intraoral radiographs where necessary.
Platelet Function Studies
These were carried out on the siblings on two occasions. They had not been exposed to aspirin or any other known antiplatelet agent in the two weeks prior to testing nor to recent testing with desmopressin. Platelet counts were obtained from a Coulter S Plus III profile. Template bleeding times were performed by a standard technique [17] . Platelet aggregation of platelet-rich plasma was measured within three hours in a Bio/data model PAP-3 aggregometer; maximum response at three minutes was recorded after addition of ADP (final concentration 2.0 /iM/1), collagen (2 /ig/ml), arachidonate (1.5 mM/1), adrenalin (100 /iM/1) and ristocetin (1.0 mg/ml) [17] . Platelet adenine nucleotide levels were measured by reverse phase high performance liquid chromatography (Pye Unicam LC) after perchloric acid extraction/potassium hydroxide neutralization [18] .
RESULTS
The clinical features of Albright's hereditary osteodystrophy and pseudohypoparathyroidism are closely linked in this family (Fig. 1) . There is no apparent HLA linkage. The mother and four of five siblings had short stature, shortened fourth and fifth metacarpals and siblings Hi and II 2 had subcutaneous calcification whilst siblings II 2 and II 3 had intracranial calcification, revealed by skull radiographs. Sibling II| had had a grand mal seizure as a child and siblings II), II 3 and II 6 had symptoms of neuromuscular hyperexcitability, with Chvostek's sign positive on some occasions. Table 2 shows the results of thyroid function assessment. There was an exaggerated TSH response to thyrotrophin in all siblings. Siblings II|, IIj and II 5 had mild hypothyroidism. Sibling II 6 had elevated TSH but normal T 3 and T 4 levels. The rise in plasma T 3 in response to endogenous TSH was impaired in subject II1, as was her response to bovine TSH (data not shown). Basal thyroid function of the mother and that of sibling II4 was normal. 
Thyroid Function
Prolactin
Basal prolactin levels were normal in all siblings. Response to thyrotrophin was suboptimal in all siblings (Table 2) .
Gonadal Function (Tables 3 and 4) Sibling Ii was referred with oligomenorrhoea since the menarche at about 11 years of age. Her basal gonadal steroids were abnormally low and the gonadotrophin response to LHRH was exaggerated. She also had evidence of ovarian insensitivity to follicle stimulating hormone, with no rise of oestradiol in response to gonadotrophin hyperstimulation. All tests were performed when she had been amenorrhoeic for three months. Sibling II 5 also had abnormal basal gonadal steroids, with elevated basal gonadotrophins but a normal luteinizing hormone release hormone test. Sibling IT 2 had normal basal steroids and gonadotrophins but an exaggerated response to luteinizing hormone releasing hormone. The luteinizing hormone releasing hormone test results of other siblings were within normal limits.
All male siblings had normal gonadal responses to exogenous gonadotrophins.
Hypothalamic-pituitary-adrenal Axis
The adrenal response to exogenous corticotrophin was normal in all subjects (data not shown). All siblings had a normal cortisol response to hypoglycaemia (blood glucose < 2.2 mmol/1) with peak levels ranging from 544 to 914 nmol/1. (Fig. 2) The plasma cyclic AMP response to glucagon infusion was blunted in Sibling II 5 in comparison to other subjects. Normal response is not absolutely defined but conclusions drawn by comparison of groups: a response of < 350 pmol/ml at 10-15 minutes is probably abnormal [11, 19] . The increase in blood glucose in response to intravenous glucagon was, however, normal in all subjects (data not shown).
Hepatic Response to Glucagon
Growth Hormone (Table 5) Growth hormone responses to growth hormone releasing hormone and to hypoglycaemia were normal in all subjects. There was no growth hormone response to thyrotrophin (data not shown), but the response to glucagon was normal in all subjects (data not shown). (Table 6) All siblings showed a normal urinary concentrating ability, and all but Sibling II 3 had small increases in plasma vasopressin after water deprivation. This subject had a slight decrease in level but normal urinary concentration and, therefore, evidence of normal renal responsiveness to vasopressin. The increase in vasopressin in Siblings 11 1 and II2 was just below the normal range [20] but despite this a normal urinary concentration was achieved and there was certainly no evidence of renal resistance to vasopressin.
Renal Response to Vasopressin
Oral Observations
All five subjects exhibited poor oral hygiene, gross periodontal disease and extensive caries. Radiological examination revealed molar pulpstones in Sibling II3; there was an enlarged root canal in the upper left second molar together with delayed eruption of the upper right Platelet Studies (Table 7) Initial screening tests of platelet aggregation showed a reduced response to one or more agonist in Siblings TI| and II 6 , the latter being particularly abnormal. Repeat studies three months later gave results which were closer to normal but still borderline in Siblings II 2 and II 5 . Ristocetin responses were normal in all subjects. The bleeding time was at the upper limit of normal in Siblings II|, Ilsand II 6 . The total platelet nucleotides were normal, apart from a mild reduction in ADP in Sibling II|. None of the siblings had a clinical history of bleeding problems.
DISCUSSION
This family study is particularly interesting because it demonstrates the variety of expression of the syndrome (Table 8 ). The action of PTH on both kidney and bone is mediated by cyclic AMP [21] [22] [23] and infusion of PTH normally leads to a rise in urinary cyclic AMP and phosphate [16, 24] . Early studies on patients with pseudohypoparathyroidism showed that the abnormal responses to infused PTH could be separated into two distinct types: type I patients have a blunted cyclic AMP and phosphaturic response and type II patients have a normal cyclic AMP response but no phosphaturic response [25, 26] . All of the affected subjects in this kindred have type I pseudohypoparathyroidism, linked with features of Albright's hereditary osteodystrophy. They have one biochemically and somatically 'normal' sister. No HLA linkage was seen and the pattern of inheritance appears to be autosomal dominant or X-linked dominant. The pattern of inheritance of pseudohypoparathyroidism has previously been reported to occur in autosomal recessive [3] , dominant [2] and X-linked dominant [1] forms. The calcium levels in our subjects varied between normal and very low, and the PTH levels ranged from low to just above normal. Interestingly there was no inverse correlation of PTH level with the degree of hypocalcaemia. Low PTH levels despite hypocalcaemia have been reported previously in proven pseudohypoparathyroidism [6, 14, 27] , but the variability of PTH level within one sibship has not. Other studies, notably the review of 40 patients by Werder et al. [6] , have found similar variability in calcium levels, even between genetically related individuals. During the study of our patients Sibling II2 has fluctuated between normocalcaemia and mild hypocalcaemia but has always remained symptomatically normocalcaemic. Sibling II5 has so far remained normocalcaemic and other siblings are on vitamin D replacement therapy,. Two other studies have observed fluctuation of calcium levels between normal and below normal in patients with pseudohypoparathyroidism [28, 29] . Studies exploring the pathogenesis of pseudohypoparathyroidism are contradictory and the mechanism underlying the disease is still unclear. Early theories [25, [30] [31] [32] focused on a defective membrane-bound hormone-receptor adenylate cyclase complex [33] and found low levels of the G protein, essential for the coupling of receptor to the second messenger [11, 31, [34] [35] [36] [37] . This theory is further supported by the observation that the administration of exogenous dibutyryl cyclic AMP can restore the normal phosphaturic effect of PTH infusion [38] . Although other theories do exist, this is the only one which allows explanation of the observation that other hormonal axes are often observed to be abnormal in patients with pseudohypoparathyroidism, in particular those hormones which are mediated by cyclic AMP. Abnormalities of thyroid function are the most common hormonal defect associated with pseudohypoparathyroidism [11, 13, 36, 39, 40] . Levine etal. [\\] found that over one-third of subjects had mild hypothyroidism. Abnormal thyroid function occurred in four of our five siblings with pseudohypoparathyroidism, although it was usually mild. Sibling IIi was also observed to have fluctuating thyroid dysfunction during subsequent observation. It seems from our study that this is due to end-organ resistance, as there was an abnormal T 3 response to both endogenous, stimulated TSH and exogenous bovine TSH. In this family the occurrence of, and severity of, hypothyroidism is not related to 'severity' of pseudohypoparathyroidism, as represented by degree of hypocalcaemia at presentation (calcium levels were corrected before other hormonal axes were assessed).
The prolactin response to thyrotrophin was abnormal in all of our subjects. This is particularly interesting in view of the exaggerated TSH response to thyrotrophin in the presence of low T 4 levels ( Table 2) , which suggests a differential mechanism of the effect of thyrotrophin on prolactin and TSH. Carlson et al. [42] showed that six of eight subjects had impaired prolactin secretion after thyrotrophin and chlorpromazine stimulation. However Levine et al. [11] found a normal prolactin response to thyrotrophin in all subjects studied.
Gonadal dysfunction is the second most frequently reported abnormal endocrine axis associated with pseudohypoparathyroidism. Female patients in many studies have menstrual irregularities, delayed menarche and infertility [11, 12] . This seems to be due to partial end-organ resistance with high basal gonadotrophin levels, exaggerated response to luteinizing hormone releasing hormone, usually normal HMG tests and secondary sexual characteristics (and compatible ovarian histology in one patient [41] ). The findings in our female subject would support these observations and may explain her primary infertility, which is currently her major clinical problem. Gonadal dysfunction is less well documented in males with pseudohypoparathyroidism. In this family there is again inter-subject variability, one sibling having borderline hypogonadism and the remainder having exaggerated responses to luteinizing hormone releasing hormone.
The abnormal hepatic response to glucagon in Sibling II 3 (who had normocalcaemia but possible gonadal dysfunction) is remarkable for its isolation in the sibship. Similar abnormal responses in some patients with pseudohypoparathyroidism Type I have been documented by Brickman et al. [19, 43] and in these studies family members differed in their hepatic response to glucagon. Thyroid status is known to affect the hepatic response to glucagon [44] but this patient was on adequate thyroxine replacement at the time of glucagon infusion.
The other hormonal studies performed showed a normal hypothalamic-pituitary-adrenal axis, normal renal concentrating ability in response to vasopressin and normal growth hormone responses to three stimuli. These findings are in agreement with some of the literature but in contrast to other studies and further illustrate the variability of the syndrome.
The oral manifestations of pseudohypoparathyroidism in this family were few and they are therefore probably unreliable as an aid to medical diagnosis. Manifestations previously reported with pseudohypoparathyroidism include enamel hypoplasia, small crowns, enlarged pulp chambers, root canals with open apices, pulp stones, blunted roots, delayed eruption of deciduous and permanent teeth, hypodentia, thickening of the lamina dura and early tooth loss due to caries [45] [46] [47] [48] [49] [50] . Previous studies have implied that dental manifestations are common in this syndrome and early tooth loss due to caries seen by previous authors was attributed to poor enamel, large pulp chambers and mental subnormality, the latter making oral hygiene and treatment difficult. The family in this study had all attended normal school and their high degree of dental decay was considered to be attributable solely to neglect and lack of motivation.
The relationship between enamel hypoplasia and hypoparathyroidism is not clear. All of the siblings who underwent dental examination in this study had the somatic features of Albright's hereditary osteodystrophy and three siblings had occasional clinical and biochemical evidence of hypocalcaemia, although none exhibited enamel hypoplasia. This suggests that calcium levels low enough to cause neuromuscular excitation may not be severe enough to cause enamel mineralization defects. This is the reverse of the findings of many authors [51] [52] [53] , and it is probably safe to conclude that while clinical hypocalcaemia may coincide with dental abnormalities the relationship is obscure and that other factors, as yet unclear, are probably involved.
The platelet, like the erythrocyte, has been shown to have a defective membrane-bound receptor-adenylate cyclase complex in type I pseudohypoparathyroidism [37] but the functional integrity of platelets has not previously been studied. The initial abnormalities of platelet aggregation found in our subjects may have been related to hypocalcaemia, or more general metabolic and endocrinological effects of pseudohypoparathyroidism, rather than an intrinsic platelet abnormality, since more prolonged correction of plasma calcium levels gave generally more improved results and platelet nucleotide levels were essentially normal. In vitro manipulation of extracellular calcium concentration is known to alter sensitivity to platelet agonists [54] . The mild abnormalities in function during metabolic imbalance seemed to be clinically unimportant, but as the study of platelet malfunction in such syndromes has often enhanced knowledge of normal mechanisms it might be informative to explore this further in other patients with the disorder. In particular studies of intracellular calcium flux, response to calcium ionophore A23187, and platelet release of ATP and 5-hydroxytryptamine may be more informative of the platelet defect.
Thus pseudohypoparathyroidism is a complex disorder of controversial pathogenesis with inter-and intra-patient variability of parathyroid dysfunction and associated endocrine abnormalities, even in genetically related individuals. The findings in this study may well reflect a common abnormality of G protein in the cyclic AMP second messenger complex, but the finding that some hormonal axes, which are similarly mediated, remain normal, and the intra-and inter-subject variability remain unexplained. It is particularly important, therefore, that these patients are monitored to assess progression of hormonal axes from normal to subclinical to frank clinical hypofunction. It is also important that pseudohypoparathyroidism is not forgotten as a cause of the common clinical problems of hypocalcaemia, hypothyroidism and female or male infertility.
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